Literature DB >> 20333523

Complex interaction of Hb Q-Thailand and Hb E with alpha(0)-thalassemia and hereditary persistence of fetal hemoglobin in a Chinese family.

Weidong Zheng1, Yanhui Liu, Dong Chen, Kabin Rong, Yanfen Ge, Caiping Gong, Heping Chen.   

Abstract

Hemoglobin (Hb) Q-Thailand, Hb E, and other forms of thalassemia are prevalent in Southeast Asia including China. We report a hitherto undescribed condition in which four forms of Hb defects co-segregate. The proband was a 20-year-old Chinese man who presented with moderate hypochromic microcytosis with Hb 73 g/l, hematocrit (Hct) 27.0%, mean corpuscular volume 57.6 fl, mean corpuscular hemoglobin 15.5 pg, and mean corpuscular hemoglobin concentration (MCHC) 268.0 g/l. Both Hb electrophoresis and high-performance liquid chromatography analysis revealed abnormal Hbs. DNA analysis demonstrated that the proband was a double heterozygote of Hb Q-Thailand and Hb E in combination with alpha(0)-thalassemia and Southeast Asian-type hereditary persistence of fetal hemoglobin (SEA-HPFH). Family study identified that her father was a double heterozygote for Hb Q-Thailand and Hb E, whereas her mother was a heterozygote for SEA-HPFH with alpha(0)-thalassemia. Moreover, his brother was a classical Hb QH disease patient. The genotype-phenotype relationship observed in this Chinese family with complex thalassemia syndromes is presented. This work will provide some clinical implications for molecular diagnosis for complex hemoglobinopathies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20333523     DOI: 10.1007/s00277-010-0935-z

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  2 in total

1.  Hemoglobin Q-Iran detected in family members from Northern Iran: a case report.

Authors:  Mohammad Khorshidi; Payam Roshan; Nooshin Bayat; Mohammad Reza Mahdavi; Hossein Najmabadi
Journal:  J Med Case Rep       Date:  2012-02-06

2.  β‑thalassemia caused by compound heterozygous mutations and cured by bone marrow transplantation: A case report.

Authors:  Liusong Wu; Zhiyu Peng; Sen Lu; Mei Tan; Ying Rong; Runmei Tian; Yuhang Yang; Yan Chen; Jindong Chen
Journal:  Mol Med Rep       Date:  2017-09-12       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.